Other languages GRI BIOPAR

Equities

Market Closed - Nasdaq Other stock markets 21:30:01 14/05/2024 BST			5-day change	1st Jan Change
0.4055 ^USD	-0.61%		+1.63%	-93.95%

04-16	GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments	MT
2023	Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12-15
Vallon Pharmaceuticals, GRI Bio Complete Merger	21/04/23
Vallon Pharmaceuticals' Stockholders Approve Merger With GRI Bio, Reverse Stock Split	21/04/23
GRI Bio, Inc. completed the acquisition of Vallon Pharmaceuticals, Inc. from group of shareholders in a reverse merger transaction.	20/04/23
Vallon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	24/02/23
Vallon Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt	23/02/23
Top Premarket Gainers	15/02/23
Top Premarket Gainers	13/02/23
Sector Update: Healthcare Stocks Mixed Premarket Friday	30/12/22
Vallon Pharmaceuticals Gets Notice of Delisting From Nasdaq; Plans Reverse Stock Split	29/12/22
Sector Update: Health Care Stocks Posting Moderate Gains	14/12/22
Sector Update: Health Care	14/12/22
Stocks Remain Relatively Flat as Investors Wait for Fed Rate-Hike Move	14/12/22
Vallon Pharmaceuticals, GRI Bio to Merge in All-Stock Deal, Shares Surge Pre-Bell	14/12/22
Investors Remain Sidelined in Premarket Trading Ahead of Fed Decision Wednesday	14/12/22
Top Premarket Gainers	14/12/22
MORNING BRIEFING - USA/Asien	14/12/22
Vallon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	03/11/22
Vallon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	28/07/22
Vallon Pharmaceuticals, Inc. Announces Board Changes	18/05/22

No results for this search